🇺🇸 FDA
Patent

US 9662317

Methods of administering tolperisone for therapeutic purposes

granted A61KA61K31/4453A61K9/0053

Quick answer

US patent 9662317 (Methods of administering tolperisone for therapeutic purposes) held by SANOCHEMIA PHARMAZEUTIKA AG expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANOCHEMIA PHARMAZEUTIKA AG
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4453, A61K9/0053, A61K9/20, A61P